Cargando…
Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis
To overcome increasing bacterial resistance to conventional antibiotics, many antimicrobial peptides (AMPs) derived from host defense proteins have been developed. However, there are considerable obstacles to their application to systemic infections because of their low bioavailability. In the prese...
Autores principales: | Lee, Hye-Ra, You, Deok-gyun, Kim, Hong Kyu, Sohn, Jang Wook, Kim, Min Ja, Park, Jong Kuk, Lee, Gi Young, Yoo, Young Do |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157825/ https://www.ncbi.nlm.nih.gov/pubmed/32291307 http://dx.doi.org/10.1128/mBio.03258-19 |
Ejemplares similares
-
A Novel Peptide Derived from the Transmembrane Domain of Romo1 Is a Promising Candidate for Sepsis Treatment and Multidrug-Resistant Bacteria
por: You, Deok-Gyun, et al.
Publicado: (2021) -
Romo1 is a mitochondrial nonselective cation channel with viroporin-like characteristics
por: Lee, Gi Young, et al.
Publicado: (2018) -
Identification of Bacterial Membrane Selectivity of Romo1-Derived Antimicrobial Peptide AMPR-22 via Molecular Dynamics
por: Kim, Hana, et al.
Publicado: (2022) -
Romo1 Inhibition Induces TRAIL-Mediated Apoptosis in Colorectal Cancer
por: Jo, Min Jee, et al.
Publicado: (2020) -
Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients
por: Kim, Hong Jun, et al.
Publicado: (2017)